CXCL10 and cutaneous mastocytosis: Our previous studies indicate that CXCL10 levels are remarkably elevated in plasma and cerebrospinal fluid of patients who died from CM than those who survive the disease after treatment confirming the observation linking elevated CXCL10 in CM patients with poor prognosis [36]–[38].